全身90Y PET在经动脉放射性栓塞剂量测定中的应用
本研究评估全身PET/CT设备uEXPLORER用于90Y PET成像及经动脉放射性栓塞剂量测定的可行性。在NEMA体模和2例患者中比较uEXPLORER与Biograph mCT,uEXPLORER在10和13 mm直径处信噪比更高,全肝吸收剂量差异低于0.2%,肝段剂量差异可达60%。
要点
- uEXPLORER在NEMA体模10和13 mm直径处信噪比高于mCT,与高空间分辨率和系统灵敏度一致。
- 2例患者全肝吸收剂量在uEXPLORER与mCT间差异低于0.2%,肝段剂量差异可达60%。
- 所有剂量体积直方图一致性良好,uEXPLORER在各肝段尾部更窄,提示图像噪声更低。
核心结论
- 本患者研究支持使用全身90Y PET进行肝脏剂量测定。
- uEXPLORER信噪比优于mCT,尤其在低计数感兴趣区,预期可改善剂量量化和肿瘤剂量测定。
研究设计与样本
- 研究评估两台PET/CT扫描仪:Biograph mCT和全身uEXPLORER。
- uEXPLORER为首个商用超高分辨率(171 cps/kBq)全身数字PET/CT设备,轴向PET视野194 cm,可在单床位扫描全身。
- 使用标准临床肿瘤学协议重建NEMA图像质量体模和2例患者的图像。
- 采用晚期门静脉期增强CT勾画肝段并创建相应感兴趣体积。
- 使用Geant4 Application for Tomographic Emission(GATE)进行蒙特卡罗模拟计算吸收剂量。
主要发现
- uEXPLORER在10和13 mm直径处显示更高的信噪比,与其高空间分辨率和系统灵敏度一致。
- 2例患者全肝吸收剂量在uEXPLORER与mCT之间一致性极好,差异低于0.2%。
- 比较肝段剂量时观察到高达60%的较大差异。
- 所有剂量体积直方图一致性良好,uEXPLORER在所有肝段尾部更窄,表明图像噪声更低。
- 通过均方根误差量化体模剂量与解析基准真值之间的差异。
关键数值与推荐
- NEMA体模6个球体直径范围为10至37 mm。
- uEXPLORER轴向PET视野为194 cm,分辨率参数为171 cps/kBq。
- 全肝吸收剂量差异低于0.2%,肝段剂量差异可达60%。
临床怎么用
- 作者认为本患者研究支持使用全身90Y PET进行肝脏剂量测定。
- 作者认为uEXPLORER信噪比优于mCT,尤其在低计数感兴趣区,预期可改善剂量量化和肿瘤剂量测定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Transarterial radioembolization (TARE) is a locoregional radiopharmaceutical therapy based on the delivery of radioactive 90Y microspheres to liver tumors. The importance of personalized dosimetry to make TARE safer and more effective has been demonstrated in recent clinical studies, stressing the need for quantification of the dose-response relationship to ultimately optimize the administered activity before treatment and image it after treatment. 90Y dosimetric studies are challenging because of the lack of accurate and precise methods but are best realized with PET combined with Monte Carlo simulations and other image modalities to calculate a segmental dose distribution. The aim of this study was to assess the suitability of imaging 90Y PET patients with the total-body PET/CT uEXPLORER and to investigate possible improvements in TARE 90Y PET-based dosimetry. The uEXPLORER is the first commercially available ultra-high-resolution (171 cps/kBq) total-body digital PET/CT device with a 194-cm axial PET field of view that enables the whole body to be scanned at a single bed position. Methods: Two PET/CT scanners were evaluated in this study: the Biograph mCT and the total-body uEXPLORER. Images of a National Electrical Manufacturers Association (NEMA) image-quality phantom and 2 patients were reconstructed using our standard clinical oncology protocol. A late portal phase contrast-enhanced CT scan was used to contour the liver segments and create corresponding volumes of interest. To calculate the absorbed dose, Monte Carlo simulations were performed using Geant4 Application for Tomographic Emission (GATE). The absorbed dose and dose-volume histograms were calculated for all 6 spheres (diameters ranging from 10 to 37 mm) of the NEMA phantom, the liver segments, and the entire liver. Differences between the phantom doses and an analytic ground truth were quantified through the root mean squared error. Results: The uEXPLORER showed a higher signal-to-noise ratio at 10- and 13-mm diameters, consistent with its high spatial resolution and system sensitivity. The total liver-absorbed dose showed excellent agreement between the uEXPLORER and the mCT for both patients, with differences lower than 0.2%. Larger differences of up to 60% were observed when comparing the liver segment doses. All dose-volume histograms were in good agreement, with narrower tails for the uEXPLORER in all segments, indicating lower image noise. Conclusion: This patient study is compelling for the use of total-body 90Y PET for liver dosimetry. The uEXPLORER scanner showed a better signal-to-noise ratio than mCT, especially in lower-count regions of interest, which is expected to improve dose quantification and tumor dosimetry.
引用
- Costa G, Spencer B, Omidvari N, et al. Radioembolization Dosimetry with Total-Body 90Y PET. J Nucl Med. 2021. PMID: 34795015. doi:10.2967/jnumed.121.263145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。